In last trading session, DarioHealth Corp (NASDAQ:DRIO) saw 70925.0 shares changing hands with its beta currently measuring 1.44. Company’s recent per share price level of $0.72 trading at $0.05 or 6.85% at ring of the bell on the day assigns it a market valuation of $24.56M. That closing price of DRIO’s stock is at a discount of -261.11% from its 52-week high price of $2.60 and is indicating a premium of 6.94% from its 52-week low price of $0.67. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 94.53K if we extend that period to 3-months.
For DarioHealth Corp (DRIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.16 in the current quarter.
DarioHealth Corp (NASDAQ:DRIO) trade information
Upright in the green during last session for gaining 6.85%, in the last five days DRIO remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $0.72 price level, adding 23.03% to its value on the day. DarioHealth Corp’s shares saw a change of -58.13% in year-to-date performance and have moved -7.67% in past 5-day. DarioHealth Corp (NASDAQ:DRIO) showed a performance of -24.20% in past 30-days. Number of shares sold short was 1.92 million shares which calculate 30.76 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10.75 to the stock, which implies a rise of 93.3% to its current value. Analysts have been projecting 7.5 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -941.67% in reaching the projected high whereas dropping to the targeted low would mean a loss of -941.67% for stock’s current value.
DarioHealth Corp (DRIO) estimates and forecasts
Statistics highlight that DarioHealth Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -50.67% of value to its shares in past 6 months, showing an annual growth rate of 57.51% while that of industry is 15.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 31.91% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 7.41M for the same. And 1 analysts are in estimates of company making revenue of 8.14M in the next quarter. Company posted 3.62M and 5.76M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 34.16% during past 5 years.
DarioHealth Corp (NASDAQ:DRIO)’s Major holders
Insiders are in possession of 17.71% of company’s total shares while institution are holding 23.57 percent of that, with stock having share float percentage of 28.64%. Investors also watch the number of corporate investors in a company very closely, which is 23.57% institutions for DarioHealth Corp that are currently holding shares of the company. NANTAHALA CAPITAL MANAGEMENT, LLC is the top institutional holder at DRIO for having 2.39 million shares of worth $2.85 million. And as of 2024-06-30, it was holding 6.9429 of the company’s outstanding shares.
The second largest institutional holder is APPIAN WAY ASSET MANAGEMENT LP, which was holding about 1.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.9947 of outstanding shares, having a total worth of $1.64 million.
